Keyphrases
Pediatric
100%
T-lymphoblastic Lymphoma
60%
Lymphoblastic Lymphoma
26%
B-cell Precursors
26%
Lymphoma Patients
23%
Lymphoblastic Malignancies
21%
Extramedullary
21%
Constitutional Mismatch Repair Deficiency (CMMRD)
20%
High Prevalence
20%
Medullary Involvement
20%
F-fluorodeoxyglucose Positron Emission Tomography
20%
18F-fluorodeoxyglucose (18F-FDG)
20%
Precursor B-cell
20%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
20%
Diagnostic Work-up
20%
Positron Emission Tomography-computed Tomography (PET-CT)
20%
Precursor B-cell Lymphoblastic Lymphoma
20%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
20%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
20%
Notch1
20%
Mutational Landscape
20%
Diagnostic Biomarker
20%
Chemokine Ligands
20%
Transcriptional Landscape
20%
Lymphoblastic Leukemia
10%
B-cell Precursor ALL
9%
T-lymphoblastic
8%
Clinical Characteristics
8%
Leukemia Patients
7%
Cancer Predisposition Syndrome
7%
B-cell Malignancies
6%
Hematological Malignancies
6%
Gene Fusion
6%
Notch Gene
6%
High Risk
6%
Dutch
5%
Medicine and Dentistry
Lymphoblastic Lymphoma
63%
Pediatrics
60%
Precursor
43%
T Cell
40%
B Cell
40%
Diagnosis
40%
Disease
32%
Cancer
21%
Fluorodeoxyglucose
20%
Fluorine-18
20%
Acute B-Cell Lymphoblastic Leukemia
20%
Positron Emission Tomography-Computed Tomography
20%
Lymphoid Leukemia
20%
Chemokine
20%
Thymus and Activation Regulated Chemokine
20%
Biological Marker
20%
Hematologic Malignancy
6%
Gene Fusion
6%
